ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8608-8609, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36207480
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2022
Type:
Article